Patent Assignment
Reel/Frame 075185/0874
Assignment of Assignor's Interest
Recorded: 2026-07-07
Pages: 6
Assignor
CASTELLANOS-RIZALDOS, ELENA
Executed: 2026-06-02
Assignee
ALNYLAM PHARMACEUTICALS, INC.
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(2)
Retinal Binding Protein 4 (RBP4) Irna Compositions and Methods of Use Thereof
Application:
63/208,027 →
Compositions and Methods for Treating or Preventing Stargardt's Disease and/or Retinal Binding Protein 4 (RBP4)-Associated Disorders
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 25, 2022
From: FITZGERALD, KEVIN; ERBE, DAVID; ZUBER, JEFFREY
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 060013/0534 →
Assignment of Assignor's Interest
Dec 1, 2022
From: FITZGERALD, KEVIN; ERBE, DAVID; ZUBER, JEFFREY; GOLLOB, JARED A.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 061940/0877 →
Assignment of Assignor's Interest
Jan 2, 2024
From: FITZGERALD, KEVIN; ERBE, DAVID; ZUBER, JEFFREY; GOLLOB, JARED A.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 065993/0978 →
Security Interest
Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →